1. Curative surgery for primary squamous cell carcinoma of the liver: a rare case study.
- Author
-
Okuda Y, Abe T, Ikeda M, Kurihara K, Shimizu A, Oshita A, Yonehara S, and Hanada K
- Subjects
- Female, Humans, Aged, 80 and over, Biomarkers, Tumor, Prognosis, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Liver pathology, Keratins, Carcinoma, Squamous Cell surgery, Carcinoma, Squamous Cell pathology
- Abstract
Primary squamous cell carcinoma (SCC) of the liver is an extremely rare disease with a very poor prognosis. An 83-year-old woman was referred to our hospital with left abdominal pain. Laboratory data showed mildly elevated C-reactive protein and biliary enzymes. The tumor markers carcinoembryonic antigen, alpha-fetoprotein, and carbohydrate antigen 19-9 were within normal ranges. Contrast-enhanced computed tomography revealed a 60 mm-sized low-density mass with poor contrast enhancement located in the lateral segment of the liver. The tumor showed low signal on T
1 -weighted magnetic resonance imaging (MRI) and high signal on T2 -weighted MRI. The cytology of bile juice showed no malignant findings. Endoscopic ultrasound-guided fine-needle aspiration biopsy was performed, which was suggestive of primary hepatic SCC. Tumor markers cytokeratin 19 fragment (CYFRA) and SCC-related antigen were elevated, at 25.2 ng/mL and 14.7 ng/mL, respectively. Left lobectomy and hilar lymph node dissection were performed. One month after surgery, the tumor marker values showed a marked decrease of 1.8 ng/mL for CYFRA and 0.3 ng/dL for SCC-related antigen. The patient has been without recurrence for more than one and half year postoperatively. SCC-related antigen and CYFRA were markedly decreased after tumor resection in this case, which may suggest their utility as tumor markers for SCC of liver origin., (© 2022. Japanese Society of Gastroenterology.)- Published
- 2023
- Full Text
- View/download PDF